Post Reply
1281-1300 of 1587
this will trail medtec....
Clearbridge can everyday up one last time
Move to 180 today
Enter this Bridge Fri. at .143. Varifas going up already. So Happy.
Research for wuhan virus?
guards80 ( Date: 11-Feb-2020 08:47) Posted:
|
I think it?s ready for the morning run
Something is brewing. 😁
https://www.straitstimes.com/world/europe/coronavirus-cases-in-wuhan-may-be-nearing-peak-study-finds
People with mild or no apparent symptoms aren' t currently being counted among cases, he told reporters Sunday. A slowdown in the increase in reported cases over the past few days is " meaningful," according to Dr Lipkin, who recently returned to the US from China, where he was advising on the outbreak. He spoke with journalists during a 14-day home quarantine.
If measures taken so far to contain the outbreak are effective, some " dramatic reductions" in infections should be observed in the third or fourth weeks of February, he said. Warmer, early-spring weather might also impede transmission, he said.
Some studies indicate an infected person may not display symptoms for 14 days or more, with testing and confirmation of cases adding to delays. This will prolong the time it will take to identify whether China' s unprecedented disease-control measures have worked.
" The next two weeks are really critical to understand what' s been happening," said Dr Benjamin Cowling, head of epidemiology and biostatistics at the University of Hong Kong, in an interview in Melbourne on Thursday.
" And, is this going to spread into other locations, or have we avoided what could be a global pandemic because of the control measures that have been implemented to date?"
The number of cases reported in Wuhan and across Hubei province has been tracking downward over the past several days.
" There has been a stabilisation in the number of cases reported from Hubei, and we' re in a four-day stable period where the number of reported cases hasn' t advanced," Dr Mike Ryan, executive director of the WHO' s Health Emergencies Programme, told reporters in Geneva Saturday.
" That' s good news and may reflect the impact of the control measures that have been put in place."
There has been a " low, but steady incidence" of infections in places outside Hubei, Dr Ryan said. It' s unclear which of those provinces may control the disease or where it might escalate, he said.
" We hope that the same stabilisation that appears to be occurring in Wuhan also occurs outside," Dr Ryan said. " But, again it' s very, very, very early to make any predictions about numbers." " This is still a very intense disease outbreak in Wuhan and Hubei, and there are still great risks in practically all of the other provinces, so we will wait and see," he said.
MEANINGFUL SLOWDOWN
People with mild or no apparent symptoms aren' t currently being counted among cases, he told reporters Sunday. A slowdown in the increase in reported cases over the past few days is " meaningful," according to Dr Lipkin, who recently returned to the US from China, where he was advising on the outbreak. He spoke with journalists during a 14-day home quarantine.
If measures taken so far to contain the outbreak are effective, some " dramatic reductions" in infections should be observed in the third or fourth weeks of February, he said. Warmer, early-spring weather might also impede transmission, he said.
Some studies indicate an infected person may not display symptoms for 14 days or more, with testing and confirmation of cases adding to delays. This will prolong the time it will take to identify whether China' s unprecedented disease-control measures have worked.
CRITICAL PERIOD
" The next two weeks are really critical to understand what' s been happening," said Dr Benjamin Cowling, head of epidemiology and biostatistics at the University of Hong Kong, in an interview in Melbourne on Thursday." And, is this going to spread into other locations, or have we avoided what could be a global pandemic because of the control measures that have been implemented to date?"
The number of cases reported in Wuhan and across Hubei province has been tracking downward over the past several days.
" There has been a stabilisation in the number of cases reported from Hubei, and we' re in a four-day stable period where the number of reported cases hasn' t advanced," Dr Mike Ryan, executive director of the WHO' s Health Emergencies Programme, told reporters in Geneva Saturday.
" That' s good news and may reflect the impact of the control measures that have been put in place."
There has been a " low, but steady incidence" of infections in places outside Hubei, Dr Ryan said. It' s unclear which of those provinces may control the disease or where it might escalate, he said.
" We hope that the same stabilisation that appears to be occurring in Wuhan also occurs outside," Dr Ryan said. " But, again it' s very, very, very early to make any predictions about numbers." " This is still a very intense disease outbreak in Wuhan and Hubei, and there are still great risks in practically all of the other provinces, so we will wait and see," he said.
yes they do research and diagnostics. once they found any cure for wuhan virus this clearbridge will be rocket to the moon
gravity8888 ( Date: 10-Feb-2020 23:34) Posted:
|
Isn't that biolidics? Hee
Clearbridge BioMedics, a spin-off company from NUS and MIT, specialises in novel platforms with applications in oncology research and diagnostics.
Clearbridge BioMedics Pte. Ltd. (the &ldquo Investee&rdquo ) specialises in novel platforms with applications in oncology research and diagnostics.
It is a spin-off from the National University of Singapore (NUS) / SMART Massachusetts Institute of Technology (MIT) and is the first incubatee of Clearbridge Accelerator,
a high-technology incubator backed by the Singapore Government&rsquo s National Research Foundation (NRF).
Utilising patented award-winning microfluidic technologies, Clearbridge BioMedics aims to provide the next generation of non-invasive liquid biopsy approaches for cancer screening,
diagnosis, staging, personalized medicine and treatment monitoring. Using a simple standard blood sample,
the ClearCell® FX1 System by ClearBridge BioMedics enable medical professionals to precisely detect the evolution of circulating tumour cells (CTC).
This is achieved through a proprietary rare cell enrichment system that enrich cancer cells from a liquid biopsy.
Understanding the dynamic and complex nature of cancer cell mutation is critical for the creation of a precise, tailored treatment and proactive monitoring.
Headquartered in Singapore, ClearBridge BioMedics currently have customers across Asia, Europe and North America.
I think business is mainly from the phillipines and Indonesia
nqing87 ( Date: 10-Feb-2020 21:41) Posted:
|
2 possibilities
- gap up kena short down
- sell on news
- gap up kena short down
- sell on news
trademaster ( Date: 10-Feb-2020 19:06) Posted:
|
tmr price action u will know
nqing87 ( Date: 10-Feb-2020 21:41) Posted:
|
yes im aware of this link.. im just not sure if their laboratories can do such coronavirus testing? i think their main revenue contributor is from Indonesia, which it seems that Indonesia is not doing tests on coronavirus
OKAYCAN ( Date: 10-Feb-2020 21:36) Posted:
|
https://www.businesstimes.com.sg/companies-markets/hot-stocks-healthcare-related-plays-back-in-vogue-supermarket-operators-see-strong
nqing87 ( Date: 10-Feb-2020 21:12) Posted:
|
clearbridge business got relation to coronavirus meh?
| guards80 ( Date: 10-Feb-2020 20:47) Posted: |
Provided shortist don't come in so early, at least short at 18x mah, more shiok for them
happietrade ( Date: 10-Feb-2020 20:36) Posted:
|